Graphic: National Health Ministries -- Health, healing and whoeness in body, mind and spirit
PC(USA) Seal
 
 
         
  Hepatitis  
         
 

This information is being provided in response to questions and concerns generated by several recent and well publicized out breaks of Hepatitis A. Hepatitis A is a typically mild and controllable illness, and while certain areas of the United States do have a higher infection rate—placing people who live in or visit those regions at greater risk—the rate of infection in the United States has decreased each year since 1990. Worldwide there are certain regions with substantially higher incidence rates than the United States. People who live in or visit these countries are also at greater risk. Current outbreaks of Hepatitis A have been covered more widely in the media—perhaps as a response to rise in sensitivity around communicable diseases stemming from a fear of bio-terrorism.

 
         
 

Hepatitis A continues to diminish as a threat in the United States each year—at least in part because a reliable and effective vaccine is now available. The following information should be helpful. Typically, we hear about five forms of Hepatitis, conveniently named:

  Graphic: Graph showing Hepatitis A indicence occurrances between 1987-97 and 2002.
Graph showing Hepatitis A indicence occurrances between 1987-97 and 2002.
 
         
  Hepatitis A  
         
 

Hepatitis A is a liver disease caused by the Hepatitis A virus (HAV). Hepatitis A can affect anyone. In the United States, Hepatitis A can occur in situations ranging from isolated cases of disease to widespread epidemics. It is the form usually identified after an "outbreak" and is spread through contaminated food and water. It is rarely fatal and most often causes jaundice, a yellowing of the skin due to reduced liver function, and flu-like symptoms that can persist for weeks. Unlike other forms of Hepatitis, it does not cause a chronic, lingering infection. There is a safe and proven vaccine readily available.

The following information has been condensed from several Centers for Disease Control and Prevention (CDC) resources.

What are the signs and symptoms of Hepatitis A?

  • jaundice
  • fatigue
  • abdominal pain
  • loss of appetite
  • nausea
  • diarrhea
  • fever

Persons with Hepatitis A virus infection may not have any signs or symptoms of the disease. Older persons are more likely to have symptoms than children. Symptoms usually last less than two months; a few persons are ill for as long as six months. The average incubation period for Hepatitis A is 28 days (range: 15–50 days).

How do you know if you have Hepatitis A?
A blood test (IgM anti-HAV) is needed to diagnose Hepatitis A. Talk to your health care provider or someone from your local health department if you suspect that you have been exposed to Hepatitis A or any type of viral Hepatitis.

What causes Hepatitis A?
Hepatitis A virus (HAV)

What are the long-term effects?

  • There is no chronic (long-term) infection.
  • Once you have had Hepatitis A you are immune and cannot get it again.
  • About 15 percent of people infected with HAV will have prolonged or relapsing symptoms over a six to nine month period.

How is Hepatitis A transmitted?

  • HAV is found in the stool (feces) of persons with Hepatitis A.
  • HAV is usually spread from person to person by putting something in the mouth (even though it may look clean) that has been contaminated with the stool of a person with Hepatitis A. This underlines the need for sanitary and hygienic practices in restaurants, child care centers, public restrooms, hotels and other heavily trafficked places.

Who is most at risk for contracting Hepatitis A?

Risk
Disease Rate
Peak Age of Infection
Transmission Patterns
             
High
Low to High
Early childhood
Person to person; outbreaks uncommon
Moderate
High
Late childhood/ young adults
Person to person; food and waterborne outbreaks
Low
Low
Young adults
Person to person; food and waterborne outbreaks
Very low
Very low
Adults
Travelers; outbreaks uncommon

Persons who are in the following risk categories should speak with their health care provider about receiving the vaccination.

 
         
  Persons traveling to or working in countries that have high or intermediate rates of Hepatitis A.
All persons traveling to or working in countries that have high or intermediate rates of Hepatitis A should be vaccinated or receive immune globulin before traveling. Persons from developed countries who travel to developing countries are at high risk for Hepatitis A.
  Graphic: Graph showing geographic prevalence of Hepatitis A Virus infection.
Graph showing geographic prevalence of Hepatitis A Virus infection.
 
         
  Such persons include tourists, military personnel, mission personnel, and others who work or study abroad in countries that have high or intermediate levels of Hepatitis A. The risk for Hepatitis A exists even for travelers to urban areas, those who stay in luxury hotels, and are careful about what they drink and eat.

Children in states, counties, and communities where rates of Hepatitis A were/are at least twice the national average during the baseline period of 1987-1997. [Your local health department should be able to tell you if you are living in a high risk community.]
Children living in states, counties, and communities where rates of Hepatitis A are at least twice the national average (greater than or equal to 20cases/1,000,000) in the baseline period should be routinely vaccinated beginning at two years of age. Vaccination of children before they enter school should receive highest priority, followed by vaccination of older children who have not been vaccinated.

Men who have sex with men
Sexually active men (both adolescents and adults) who have sex with men should be vaccinated. Hepatitis A outbreaks among men who have sex with men have been reported frequently. Recent outbreaks have occurred in urban areas in the United States, Canada, and Australia.

Persons who have chronic liver disease
Persons with chronic liver disease who have never had Hepatitis A should be vaccinated, as there is a higher rate of fulminant (rapid onset of liver failure, often leading to death) Hepatitis A among persons with chronic liver disease. Persons who are either awaiting or have received liver transplants also should be vaccinated.

Persons who have clotting-factor disorders
Persons who have never had Hepatitis A and who are administered clotting-factor concentrates, especially solvent detergent-treated preparations, should be given Hepatitis A vaccine.

All persons with hemophilia (Factor VIII, Factor IX) who receive replacement therapy should be vaccinated because there appears to be an increased risk of transmission from clotting-factor concentrates that are not heat inactivated.

Injecting drug users (legal or illegal)
Vaccination is recommended for all injecting drug users who share needles and all those who use any illegal-drug—since the safety of the illegal substance cannot be assured.

Those persons who have occupational risk for infection including:

Health-care workers are not at increased risk for Hepatitis A unless there is a breech in the hospital infection control procedures. Routine precautions should prevent transmission to hospital staff.

Day-care staff and attendees in locations where day-care centers are playing a role in sustaining community-wide outbreaks. In this situation, consideration should be given to adding Hepatitis A vaccine to the prevention plan for children and staff in the involved center(s).

Persons who work with Hepatitis A virus-infected primates or with Hepatitis A virus in a research laboratory setting should be vaccinated. No other groups have been shown to be at increased risk for Hepatitis A virus infection because of occupational exposure.

How is Hepatitis A prevented?

  • Hepatitis A vaccination provides protection before one is exposed to Hepatitis A virus. Hepatitis A vaccine has been licensed in the United States for use in persons two years of age and older for persons who are more likely to get Hepatitis A virus infection or are more likely to get seriously ill if they do get Hepatitis A.
  • Short-term protection against Hepatitis A is available from immune globulin. It can be given before and within two weeks after coming in contact with HAV. Immune globulin is a preparation of antibodies that provides short-term protection for persons who have already been exposed to Hepatitis A virus. It must be given within two weeks after exposure to Hepatitis A virus for maximum protection.
  • Always wash your hands with soap and water after using the bathroom, changing a diaper, and before preparing and eating food. One-third of Americans had evidence of past infection (immunity).
  • Food-borne outbreaks of Hepatitis A can originate from foods prepared before the food handler has clinical symptoms. Most reported outbreaks have been traced to symptomatic rather than asymptomatic persons.
  • Uncooked foods have most frequently been associated with food-borne hepatitis because normal cooking temperatures inactivate HAV. However, cooked foods handled after cooling and foods that were contaminated and then cooked with insufficiently high internal temperature to inactivate HAV have also been implicated.
  • Although poor hygiene practices among food handlers increase the chance of transmission of virus, outbreaks have occurred even when food handlers' personal hygiene practices were described as "acceptable" and "generally good."

More information about Hepatitis A is found at www.cdc.gov/ncidod/diseases/Hepatitis/a/index.htm.

 
         
  Note:
Despite the availability of highly effective vaccines and recommendations that have been in place for several years, there were more than 13,000 cases of Hepatitis A reported and more than 8,000 cases of Hepatitis B reported (to the CDC) in 2000, making these diseases among the most frequently reported vaccine-preventable diseases in the United States.
 
         
 
 

Hepatitis B

Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called Hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure and death.

There are longstanding recommendations to vaccinate adults at increased risk for Hepatitis B virus (HBV) infection. However, widespread nationwide programs do not exist that integrate Hepatitis B immunization into programs that serve high-risk adults. Since 1996, more than one-third of all patients reported and diagnosed with acute Hepatitis B reported prior treatment for a sexually transmitted disease (STD).

Hepatitis B vaccine is available for all age groups to prevent Hepatitis B virus infection.

More resources can be found at the following link www.cdc.gov/ncidod/diseases/Hepatitis/b/index.htm.

 
         
 
 

Hepatitis C

Hepatitis C is a disease of the liver caused by the Hepatitis C virus (HCV).
Risk factors for Hepatitis C include the following groups. If you or someone you know falls into one of the following groups, contact your health care provider for a blood test:

  • If you were notified you received blood from a donor who later tested positive for Hepatitis C.
  • If you have ever injected illegal drugs, even if you experimented a few times many years ago.
  • If you received a blood transfusion or solid organ transplant before July, 1992.
  • If you were a recipient of clotting factor(s) made before 1987.
  • If you have ever been on long-term kidney dialysis.
  • If you have evidence of liver disease (e.g., persistently abnormal ALT levels)

More information about Hepatitis C can be found at www.cdc.gov/ncidod/diseases/Hepatitis/c/index.htm.

 
         
 
 

Hepatitis D

Hepatitis D is a liver disease caused by the Hepatitis D virus (HDV), a defective virus that needs the Hepatitis B virus to exist. Thus, Hepatitis D virus (HDV) is only found in persons infected with the Hepatitis B virus. Hepatitis D virus infection is transmitted by blood and blood products. The risk factors for infection are similar to those for Hepatitis B virus infection. The Hepatitis D virus most often infects intravenous drug users.

A person can acquire Hepatitis D virus infection at the same time as he/she is infected with the Hepatitis B virus. This is called co-infection and should be suspected in a particularly aggressive acute Hepatitis B infection.

A patient with Hepatitis B can be infected with Hepatitis D virus at any time after acute Hepatitis B virus infection. This is called super-infection and should be suspected in a patient with chronic Hepatitis B whose condition suddenly worsens. It is diagnosed by the presence of antibodies against the Hepatitis D virus.

An excellent site for more information about Hepatitis D provided through Columbia University at http://cpmcnet.columbia.edu/dept/gi/hepD.html.

 
         
 
 

Hepatitis E

Hepatitis E is a liver disease caused by the Hepatitis E virus (HEV) transmitted in much the same way as Hepatitis A virus. Hepatitis E, however, does not occur often.

The incubation period following exposure to HEV ranges from 15 to 60 days (mean, 40 days). Typical clinical signs and symptoms of acute Hepatitis E are similar to those of other types of viral Hepatitis and include abdominal pain anorexia, dark urine, fever, hepatomegaly, jaundice, malaise, nausea, and vomiting. Other less common symptoms include arthralgia, diarrhea, pruritus, and urticarial rash. The period of infectivity following acute infection has not been determined but virus excretion in stools has been demonstrated up to 14 days after illness onset. In most Hepatitis E outbreaks, the highest rates of clinically evident disease have been in young to middle-age adults; lower disease rates in younger age groups may be the result of an icteric and/or subclinical HEV infection. No evidence of chronic infection has been detected in long-term follow-up of patients with Hepatitis E.

More information about Hepatitis E can be found at www.cdc.gov/ncidod/diseases/Hepatitis/e/index.htm.

 
         
PC(USA) Home (Link)
     
   
  Home  
   
  News and Training  
   
  Advocacy  
   
  Congregational
Health Ministries
 
   
  Health Information  
   
  Resources  
  Line  
  E-Community Connections  
   
  Staff  
   
  Parish Nursing  
   
     
   
     
   
     
   
     
   
     
     
   
     
  Link to Top of Page  
 
Contact PC(USA)